IL6 and acute respiratory distress syndrome: We also evaluated the potential values of selected biomarkers in the prediction of survival rates, of which higher levels of CXCL6, interleukin-6 (IL-6), or insulin-like growth factor binding protein 4 (IGFBP-4) in the circulation were correlated with poor prognosis in patients with SP-ARDS.